MEDALANE HAPPA CEO AT BASA

Loading player...
Over the last 21 years of business and arts partnerships, BASA has collected valuable research drawn from different initiatives, including BASA’s ArtsTrack Research, BASA Supporting Grants, BASA Awards, and other arts-based initiatives, which is being put to productive use as we move forward into the next decade. This research provides crucial insights into best practice, shifts and trends, and return on investment, and is being used to inform the next generation of arts business partnerships – once again underlining BASA’s value to the government, business and the arts sector in the new decade.

In particular, BASA supports our members on a consultancy basis, using our research and broader partnerships to provide a diversity of businesses with arts-based intelligence and arts-based initiatives as a way of significantly supporting their strategic goals. BASA additionally uses our research learnings for advocacy, to create opportunities, and to connect the public sector, private sector and the arts sector (or third sector) – both in South Africa and across our borders.
25 Jul 2019 12PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min